Shared on04 Aug 25Fair value Increased 6.32%
Despite a notable rise in both the discount rate and future P/E ratio, analysts have increased their fair value estimate for Aster DM Healthcare, with the consensus price target rising from ₹619.80 to ₹659.00. What's in the News Incorporated two wholly owned subsidiaries in Bengaluru: Aster DM Super-Specialty Hospital (Yeswanthpur) and Aster DM Super-Specialty Hospital (Sarjapur), to set up and operate new hospitals.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 0.019%
AnalystConsensusTarget has decreased revenue growth from 18.4% to 16.1%.
Shared on02 Apr 25Fair value Increased 0.89%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Decreased 7.19%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.